Growth disorders2019-09-16T12:13:20+00:00

C-type natriuretic peptide analogue increases growth velocity in children with achondroplasia

June 30th, 2019|Categories: Bone disorders, Editor's pick, Growth disorders, News, News Content, Pituitary/growth disorders|

Daily treatment with subcutaneous vosoritide leads to a sustained increase in annualised growth velocity, with generally mild side effects, in children with achondroplasia, show data published in The New England Journal of Medicine.

Go to Top